Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2001
10/18/2001WO2001077377A2 Diagnosis of diseases associated with dna replication by assessing dna methylation
10/18/2001WO2001077376A2 Diagnosis of diseases associated with metastasis
10/18/2001WO2001077375A2 Diagnosis of diseases associated with gene regulation
10/18/2001WO2001077374A2 Method for identifying and isolating genome fragments with linkage disequilibrium
10/18/2001WO2001077372A2 Identification of biological (micro) organisms by detection of their homologous nucleotide sequences on arrays
10/18/2001WO2001077366A1 Positive selection method, compounds, host cells and uses thereof
10/18/2001WO2001077361A1 Human immunoglobulin-producing gnotobiotics
10/18/2001WO2001077358A2 Herpes viruses for immune modulation
10/18/2001WO2001077357A2 Chromosomal vectors and uses thereof
10/18/2001WO2001077356A2 Protein kinase stress-related proteins and methods of use in plants
10/18/2001WO2001077355A2 Signal transduction stress-related proteins and use in plants
10/18/2001WO2001077354A2 Cell cycle stress-related proteins and methods of use in plants
10/18/2001WO2001077353A2 Expression of pollen allergens in plastids
10/18/2001WO2001077352A2 Vectors and method for selecting cdna molecules, which comprise an open reading frame
10/18/2001WO2001077351A1 Vectors and methods for dual protein expression in pichia pastoris and escherichia coli
10/18/2001WO2001077350A2 Compositions and methods for inhibiting gene expression
10/18/2001WO2001077349A1 Use of 3'-utr's from cysteine proteinase genes cpb2 and cpb2.8 of leishmania for directing stage-specific expression
10/18/2001WO2001077348A2 Ketogulonigenium endogenous plasmids
10/18/2001WO2001077347A2 Ketogulonigenium shuttle vectors
10/18/2001WO2001077346A1 Use of the nucleotide sequence of the lactobacillus casei lactose operon promoter for regulating gene expression by means of an antiterminator protein
10/18/2001WO2001077344A1 Vectors
10/18/2001WO2001077343A1 MUIR-TORRE-LIKE SYNDROME INFhit DEFICIENT MICE
10/18/2001WO2001077342A1 Multivalent antibodies and uses therefor
10/18/2001WO2001077341A2 Mammalian heparanase
10/18/2001WO2001077340A1 Identification of a dual specificity phosphatase: dusp-10
10/18/2001WO2001077339A1 Human pyruvate dehydrogenese phosphatase
10/18/2001WO2001077338A2 Human protein kinases and protein kinase-like enzymes
10/18/2001WO2001077337A1 α1,4-N-ACETYLGALACTOSAMINE TRANSFERASE GENE AND PROCESS FOR PRODUCING THIS ENZYME AND N-ACETYLGALACTOSAMINE-CONTAINING COMPLEX CARBOHYDRATE
10/18/2001WO2001077336A2 Acyl-coa dehydrogenase mutant and uses thereof
10/18/2001WO2001077335A2 Listeria monocytogenes genome, polypeptides and uses
10/18/2001WO2001077334A2 Lactococcus lactis genome, polypeptides and uses
10/18/2001WO2001077333A1 Cloning of the a. thaliana ms-1 gene involved in male sterility
10/18/2001WO2001077332A2 Compositions and methods related to canine igg and canine il-13 receptors
10/18/2001WO2001077331A1 Human trp-like calcium channel protein-2 (tlcc-2)
10/18/2001WO2001077330A2 G protein-coupled receptors
10/18/2001WO2001077329A2 Human twik molecules and uses thereof
10/18/2001WO2001077328A1 Methods of using growth factors for treating heart disease
10/18/2001WO2001077327A1 THE HIGH BONE MASS GENE OF 11q13.3
10/18/2001WO2001077326A1 Novel g protein-coupled receptor protein and dna thereof
10/18/2001WO2001077325A1 Novel g protein-coupled receptor protein and dna thereof
10/18/2001WO2001077324A1 Dna immunization vectors
10/18/2001WO2001077323A1 Gene coding for erbin, and diagnostic and therapeutic uses thereof
10/18/2001WO2001077322A1 Cryptic-like secreted protein
10/18/2001WO2001077321A2 Identification of a human gaba transporter
10/18/2001WO2001077320A2 Regulation of human hm74-like g protein coupled receptor
10/18/2001WO2001077319A2 Genetic manipulation of clostridium difficile
10/18/2001WO2001077318A1 Regulatory element from a sugarcane proline rich protein and uses thereof
10/18/2001WO2001077316A2 Method of nucleic acid recovery
10/18/2001WO2001077315A1 Signal sequence trapping
10/18/2001WO2001077314A1 MODIFIED α2,3-SIALYLTRANSFERASE GENE AND PROCESS FOR PRODUCING α2,3-SIALYLTRANSFERASE AND COMPLEX SACCHARIDE CONTAINING SIALIC ACID
10/18/2001WO2001077312A1 A transformant for screening of inhibitors for human immunodeficiency virus
10/18/2001WO2001077311A2 Transcription factor stress-related proteins and methods of use in plants
10/18/2001WO2001077310A1 A promoter cv20oxp which regulates the integument-specific expression of a gibberellin 20-oxidase gene in developing seeds of watermelon and a method for generating seedless fruits using the promoter
10/18/2001WO2001077306A2 Plant raffinose saccharide biosynthetic enzymes
10/18/2001WO2001077304A1 Method of producing adenoviral vector stocks
10/18/2001WO2001077298A2 Human müllerian duct-derived epithelial cells and methods of isolation and uses thereof
10/18/2001WO2001077295A1 Mutant bank
10/18/2001WO2001077294A2 Hpv-specific short-mers
10/18/2001WO2001077291A2 Polynucleotides encoding novel secreted proteins
10/18/2001WO2001077181A2 Anti-rhesus d monoclonal antibodies
10/18/2001WO2001077179A1 Proteins with a high immunoreactivity and a method for the production thereof
10/18/2001WO2001077177A2 Gpcr-proteins and nucleic acids encoding same
10/18/2001WO2001077176A2 E.coli blr molecules affecting antibiotic susceptibility
10/18/2001WO2001077175A2 G protein-coupled receptors
10/18/2001WO2001077174A2 Human transporters and ion channels
10/18/2001WO2001077173A1 Tm4sf receptor polynucleotides, polypeptides, and antibodies
10/18/2001WO2001077172A2 Non-endogenous, constitutively activated known g protein-coupled receptors
10/18/2001WO2001077171A2 Soluble zalpha11 cytokine receptors
10/18/2001WO2001077170A2 Multiprotein-complexes comprising a nmda receptor and uses thereof
10/18/2001WO2001077169A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
10/18/2001WO2001077168A2 Compositions and methods for the therapy and diagnosis of lung cancer
10/18/2001WO2001077166A1 Novel physiologically active peptides and use thereof
10/18/2001WO2001077165A1 A novel polypeptide, human amyloid precursor protein-binding protein 12 and the polynucleotide encoding thereof
10/18/2001WO2001077164A2 Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis
10/18/2001WO2001077163A1 A novel polypeptide-human cell differenciation transcription factor 16 and the polynucleotide encoding said polypeptide
10/18/2001WO2001077162A1 A novel polypeptide-human sodium pump subunit 12 of and the polynucleotide encoding said polypeptide
10/18/2001WO2001077161A2 Gtp binding stress-related proteins and methods of use in plants
10/18/2001WO2001077159A2 An endogenous ketogulonigenium plasmid
10/18/2001WO2001077158A1 Hepatitis b core antigen fusion proteins
10/18/2001WO2001077155A2 Orfx polynucleotides and polypeptides
10/18/2001WO2001077153A2 Phage display selection of anti fungal peptides
10/18/2001WO2001077151A2 Fdrg proteins and nucleic acid molecules and uses therefor
10/18/2001WO2001077150A2 Serine-threonine kinase
10/18/2001WO2001077149A2 Regulation of human cyslt2-like gpcr protein
10/18/2001WO2001077148A2 Human lipid binding protein 1
10/18/2001WO2001077147A2 New bromodomain protein
10/18/2001WO2001077137A1 Albumin fusion proteins
10/18/2001WO2001077136A1 Compounds and methods for lowering cholesterol levels without inducing hypertriglyceridemia
10/18/2001WO2001076643A1 Macroaggregated protein conjugates as oral genetic immunization delivery agents
10/18/2001WO2001076641A1 Targeted death of cancer cells
10/18/2001WO2001076638A2 Compositions for drug delivery
10/18/2001WO2001076637A2 Peptide conjugates for drug delivery
10/18/2001WO2001076636A2 Pharmaceutical composition of modified pna molecules
10/18/2001WO2001076633A2 Targeted transfection of cells using a biotinylated dendrimer
10/18/2001WO2001076620A2 Use of vegf and homologues to treat neuron disorders
10/18/2001WO2001076564A1 Microprojectile delivery system and particulate product
10/18/2001WO2001076529A2 Fertility associated antigen and methods of use thereof
10/18/2001WO2001076451A2 Diagnosis of diseases associated with metabolism
10/18/2001WO2001076361A1 Animal and cell models for type ii diabetes and their use
10/18/2001WO2001059450A8 Cells expressing zinc finger protein for drug discovery
1 ... 2959 2960 2961 2962 2963 2964 2965 2966 2967 2968 2969 2970 2971 2972 2973 2974 2975 2976 2977 2978 2979 ... 4023